Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Revive Therapeutics Ltd. C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for rare disorders and infectious diseases. The Company is exploring the use of Bucillamine for the treatment of infectious diseases, with an initial focus on severe influenza and COVID-19. Through its subsidiary, Psilocin Pharma Corp., the Company is advancing the development of Psilocybin-based therapeutics in various diseases and disorders. The Company’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory diseases and the Company was granted Food and Drug Administration (FDA) orphan drug status designation for the use of Cannabidiol (CBD) to treat autoimmune hepatitis (liver disease) and to treat ischemia and reperfusion injury from organ transplantation.


CSE:RVV - Post by User

Comment by TheIceMan3on Jul 01, 2020 9:05pm
183 Views
Post# 31213892

RE:Psilocybin

RE:Psilocybin
Great post and quite fair of what could happen.  I originally bout in this play because of the psilocybin element to the deal, it makes a lot of sense to me and I believe it is going to be a significant part of this deal.  The bucilamine came out of no where in regards to what it could possibly do to treat COVID-19 and this a just palin luck on my part.

I'm not going to comment on what I think the share price will tomorrow but I do know if they get approval for Phase 3 in the next couple weeks or so, I am going to be an extremely happy camper, much like many of you.  The .40 - .60 that may come this week will be in the rear-view mirror.

Honestly, how many companies have a possible Covid-19 drug in phase 3 and a fantastic footprint in the psilocybin sector, which is gonna start being legal in many US States & Canada in the very near future?  

GLTA



fumperbun wrote: This company is using psilocybin to treat mental disorders as well as the bucillamine as a potential treatment for lung problems.

Totally legit and investors are looking for investments in psychedelics.

That is why this stock is going crazy and there is no real reason for it to stop rising while waiting for confirmation on the phase 3 study.

Call it what you want but this company could easily go as high as shrm did at almost 3 dollars over a short period of time.

I can see this at over a buck easily based on what i saw shrm do and the fact that bucillamine could very well go into phase 3 trials.

Now if this does go into phase 3 trials and there is no real reason why it won't.

Well then we are definitely going into the mulitiple dollar status.

And if the trials prove successful........ Yikessss.............

And this stock is trading under .50 cents.

The fact alone it could take days or weeks for confirmation tells me the worse case scenario is it rises until the announcement.

Me Likey this company.


<< Previous
Bullboard Posts
Next >>